EU conference on EDCs – program now online

Conference program focuses on criteria for endocrine disruptors, legal aspects and potential impacts on economy, ecology and health

EFSA’s work on endocrine disrupters is ongoing

EFSA gives update on their work on endocrine active substances and non-monotonic dose response; following up their Scientific Opinion of 2013

When the dose does not make the poison

Scientists comment on first proposal to integrate non-monotonic dose response in chemical risk assessment framework

EU policy on EDCs deliberately obstructed

New report reveals internal documents, details stakeholder activities in obstructing Commission work on endocrine disrupting chemicals

Coop Denmark rejects fluorinated food packaging

Coop Denmark removes microwave popcorn from shelves because packaging contains fluorinated substances

Low-dose BPA exposure has adverse effects on mammary cells

U.S. scientists show that low-dose BPA upregulates expression of c-Myc gene associated with variety of human cancers

Assessing perchlorate exposure in French infants

French study suggests that tolerable daily intake (TDI) for perchlorate could be exceeded in some children, sources of perchlorate must be fully identified to reduce exposure

Does EDC exposure contribute to acne development?

Greek researchers discuss potential contribution of EDCs to elevated androgens levels and possibly to acne development

Meetings on impact assessment to identify EDC criteria

EU Commission’s DG Sante to hold two roundtables on EDCs in April and May 2015 with Member States and MEPs respectively

EU Commission organizes conference on EDCs

One-day conference to take place on June 1, 2015 in Brussels